Search

Your search keyword '"Tibben A"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Tibben A" Remove constraint Author: "Tibben A" Publisher elsevier Remove constraint Publisher: elsevier
37 results on '"Tibben A"'

Search Results

1. ShoeCase: A data set of mock crime scene footwear impressions

5. List of Contributors

6. Development and validation of a combined liquid chromatography tandem-mass spectrometry assay for the quantification of aprepitant and dexamethasone in human plasma to support pharmacokinetic studies in pediatric patients

7. Development and validation of an LC-MS/MS method for the quantitative analysis of milciclib in human and mouse plasma, mouse tissue homogenates and tissue culture medium

8. Uncertainties in Genome Sequencing

9. Genetic Testing Expanded

10. List of Contributors

11. Summary of Key Areas for Research

12. Liquid chromatography-tandem mass spectrometric assay for the quantification of galunisertib in human plasma and the application in a pre-clinical study

13. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the quantification of lurbinectedin in human plasma and urine

14. Liquid chromatography-tandem mass spectrometry assay for the quantification of niraparib and its metabolite M1 in human plasma and urine

15. Liquid chromatography-tandem mass spectrometry assay to quantify plitidepsin in human plasma, whole blood and urine

16. Corrigendum to 'Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine' [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100]

17. Patients' and surgeons' experiences after failed breast reconstruction: A qualitative study.

18. "Watching time tick by…": Decision making for Duchenne muscular dystrophy trials.

20. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.

21. Information-seeking behaviour and coping style of women opting for either implant or DIEP-flap breast reconstruction.

22. A counselee-oriented perspective on risk communication in genetic counseling: explaining the inaccuracy of the counselees' risk perception shortly after BRCA1/2 test result disclosure.

23. Women's motives to opt for either implant or DIEP-flap breast reconstruction.

24. Family communication matters: the impact of telling relatives about unclassified variants and uninformative DNA-test results.

25. High satisfaction rates in women after DIEP flap breast reconstruction.

26. Disentangling the Babylonian speech confusion in genetic counseling: an analysis of the reliability and validity of the nomenclature for BRCA1/2 DNA-test results other than pathogenic.

27. Putting it all behind: long-term psychological impact of an inconclusive DNA test result for breast cancer.

28. Who is prone to high levels of distress after prophylactic mastectomy and/or salpingo-ovariectomy?

29. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress.

30. Attachment in families with Huntington's disease. A paradigm in clinical genetics.

31. Experience of parental cancer in childhood is a risk factor for psychological distress during genetic cancer susceptibility testing.

32. What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

37. Testing for Huntington's disease with support for all parties.

Catalog

Books, media, physical & digital resources